...
首页> 外文期刊>Oncoimmunology. >Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors
【24h】

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors

机译:与皮下肿瘤相比,调节性T细胞介导的免疫抑制在肾脏肿瘤中的差异效力

获取原文
获取原文并翻译 | 示例
           

摘要

In many cancers, regulatory T cells (Treg) play a crucial role in suppressing the effector immune response thereby permitting tumor development. Indeed, in mouse models, their depletion can promote the regression of tumors of various origins, including renal cell carcinoma when located subcutaneous (SC). In the present study, we aimed to assess the importance of Treg immunosuppression in the physiologic context of metastatic renal carcinoma (Renca) disease. To that purpose we inoculated renal tumors orthotopically, intra-kidney (IK), in mice. Treg depletions were performed using anti-CD4 antibody in wild type mice or diphtheria toxin (DT) in Foxp3(DTR) transgenic mice. Our main observation was that Treg were not the key immunosuppressive component of the IK tumoral microenvironment, compared to the same tumors located SC. We demonstrated that the CD8+ effector immune response was still suppressed in IK tumors when compared to SC tumors, following Treg depletion. Furthermore, the level of program cell death protein (PD)-1 was increased on the surface of CD4+ T cells infiltrating IK tumors compared to SC tumors. Finally, the Treg-independent immunosuppression, occurring in IK tumors, was potent enough to inhibit regression of concomitant SC tumors, normally responsive to Treg depletion. Our findings provide further insight into the immunosuppressive nature of the immune response generated in the kidney microenvironment, suggesting that it can have additional mechanisms in addition to Treg. These observations might help to identify better targets from the kidney tumor microenvironment for future cancer therapies.
机译:在许多癌症中,调节性T细胞(Treg)在抑制效应物免疫反应中起着至关重要的作用,从而使肿瘤得以发展。实际上,在小鼠模型中,它们的耗竭可以促进皮下(SC)定位的各种起源肿瘤的退化,包括肾细胞癌。在本研究中,我们旨在评估Treg免疫抑制在转移性肾癌(Renca)疾病的生理环境中的重要性。为此,我们在小鼠原位,肾脏内(IK)接种了肾脏肿瘤。使用野生型小鼠中的抗CD4抗体或Foxp3(DTR)转基因小鼠中的白喉毒素(DT)进行Treg清除。我们的主要观察结果是,与位于SC的相同肿瘤相比,Treg不是IK肿瘤微环境的关键免疫抑制成分。我们证明,Treg耗竭后,与SC肿瘤相比,IK肿瘤中的CD8 +效应免疫反应仍被抑制。此外,与SC肿瘤相比,在浸润IK肿瘤的CD4 + T细胞表面,程序细胞死亡蛋白(PD)-1的水平增加。最后,在IK肿瘤中发生的非Treg依赖性免疫抑制作用足以抑制伴随SC肿瘤消退,通常对Treg耗竭有反应。我们的发现为肾脏微环境中产生的免疫反应的免疫抑制性质提供了进一步的见识,表明它除了Treg外还可以具有其他机制。这些观察结果可能有助于从肾脏肿瘤微环境中确定更好的靶点,以用于将来的癌症治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号